Alyssa Augst is a pharmacist who is specialized in Oncology in Saint Cloud, Minnesota. Patients can reach her at 1900 Centracare Cir Ste 1600, Saint Cloud or contact her on 320-229-4927. Active license number of Alyssa Augst is 119662 for Oncology in Minnesota. Alyssa Augst is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Alyssa Augst speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Alyssa Augst
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
1900 Centracare Cir Ste 1600, Saint Cloud, Minnesota, 56303-5000
Phone:
320-229-4927
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Alyssa Augst are as mentioned below.
NPI Number:
1053285296
NPI Enumeration Date:
01 Oct, 2025
NPI Last Update On:
01 Oct, 2025
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Alyssa Augst are as mentioned below.
Specialization
License Number
State
Status
Oncology
119662
Minnesota
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5495 Ne River Rd, Sauk Rapids, Minnesota
Zip:
56379-9307
Phone Number:
320-229-4927
Fax Number:
--
Patients can reach Alyssa Augst at 1900 Centracare Cir Ste 1600, Saint Cloud, Minnesota or can call on phone at 320-229-4927.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.